Deals of the day-Mergers and acquisitions
Adds Cycle Pharmaceuticals, Legendary Entertainment, Stellantis; Updates B. Riley, H Lundbeck,
Oct 14 (Reuters) -The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:
** Stellantis STLAM.MI is not seeking to merge with or to buy other players, John Elkann, chairman of the French-Italian automaker, told news agency AFP, amid recent rumours of a tie-up with French competitor Renault RENA.PA.
nL1N3LQ0XV
** Legendary Entertainment on Monday said it had completed a buyout of Chinese conglomerate Dalian Wanda Group's remaining stake in the movie studio and will be wholly owned by Apollo Global APO.N
nL4N3LQ18H
** H Lundbeck A/S HLUNb.CO has agreed to buy U.S.-based Longboard Pharmaceuticals LBPH.O for $2.6 billion, marking the biggest deal ever by the Danish drugmaker as it seeks to bolster its portfolio with a potential blockbuster epilepsy drug.
nL4N3LQ0ON
** UK-based Cycle Pharmaceuticals reaffirmed its offer to buy Vanda Pharmaceuticals VNDA.O in a deal that values the U.S. drugmaker at $488 million, despite a regulatory setback for its stomach condition drug in September.
nL4N3LQ0Y8
** B. Riley RILY.O on Monday agreed to sell its Great American unit, which helps companies determine the value of their assets, to investment firm Oaktree Capital in a $386 million deal that would pare its debt and bolster the balance sheet.
nL1N3LQ09W
** Hong Kong-listed chip equipment maker ASMPT 0522.HK said it has received a takeover bid, but did not name the potential acquirer nor give any financial details.
nL4N3LQ0PJ
** Catalent CTLT.N has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said.
nL4N3LQ0MI
** Private equity firm MBK and Young Poong 000670.KS have secured a more than 5% stake in Korea Zinc 010130.KS through a tender offer that closed, Young Poong said in a regulatory filing.
nL1N3LQ085
** Parcel locker company InPost INPST.AS is in "very advanced talks" to buy the 70% stake it does not already own in British logistics firm Menzies, Sky News reported.
nL8N3LQ0JJ
** South Korean conglomerate Hanwha Group raised its offer for the remaining stake it does not already own in Singapore's Dyna-Mac DMHL.SI, valuing the offshore oil and gas contractor at S$790.6 million ($605.41 million).
nL4N3LQ0GS
** Singapore will block a bid by German insurer Allianz ALVG.DE to buy a majority stake in Singapore's Income Insurance but remains open to a new deal if its concerns can be addressed, Prime Minister Lawrence Wong said in a Facebook post. nL1N3LQ06I
** British luxury brand Mulberry MUL.L said it is working with advisers to evaluate Frasers' FRAS.L sweetened 111 million pound ($145.1 million) takeover proposal, after its top investor Challice declined to sell shares to the sportswear retailer. nL4N3LQ0BX
(Compiled by Rajarshi Roy and Neil J Kanatt in Bengaluru)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
